Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bioxel Gets Considerable Paclitaxel Order | Contract Pharma

What are you searching for?

Sign in
Breaking News

Bioxel Gets Considerable Paclitaxel Order

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bioxel Pharma received a paclitaxel order valued at $700,000 from a generic manufacturer in the EU. The order will be used in a generic paclitaxel drug currently marketed in Europe. Product deliveries under the order will begin this quarter.

“This is the second major paclitaxel order for Bioxel in the past month,” said Pascal Delmas, president and chief executive officer of Bioxel. “We are clearly earning customer confidence and building revenue momentum with a combination of product quality, availability and value. Since June, Bioxel has landed major Paclitaxel orders with both leading generic and second generation taxane manufacturers that total $1.8 million.”

Bioxel’s product meets the new European quality standards, effective since July 2007. Bioxel’s Drug Master File (DMF), which is registered in more than 25 countries including the U.S., Canada, and Europe, allows the company to sell paclitaxel throughout this territory.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters